XENOTHERA will participate at ESOT 2019 that will take place...
Read MoreNantes, June 21st, 2019 – XENOTHERA announces receivability after its submission of a Clinical...
Read MoreKidney graft recipients receiving anti-lymphocyte globulins of animal origin undergo unwanted immune...
Read MoreXENOTHERA has started to gather investors for a Series A round of...
Read MoreNantes, november 2017 The fresco, more than 8 meters long, has been...
Read MoreNantes, September 2017 We have been selected for the 2017 entrepreneur awards...
Read MoreAugust 25th, 2016 XENOTHERA, a young start-up from Nantes, is honored to...
Read MoreJune 10th, 2016 XENOTHERA, a young biotech who develops an innovative immunosuppressant,...
Read MoreSeptember 1st, 2015 The Medicine Faculty of Nantes is welcoming the start-up...
Read MoreJuly 24th, 2015 Several partners of XENOTHERA will be present at the...
Read MoreJuly 23th, 2015 XENOTHERA will participate in the Biopharm America that will...
Read More